European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine)Mical Paul, Jesús Rodríguez‐Baño, Elena Carrara et al.|Clinical Microbiology and Infection|2021Cited by 1k
Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort studyBelén Gutiérrez‐Gutiérrez, Mario Fernández‐Ruiz, George L. Daikos et al.|The Lancet Infectious Diseases|2017Cited by 521
Rationalizing antimicrobial therapy in the ICU: a narrative reviewJean‐François Timsit, François Barbier, Olaf L. Cremer et al.|Intensive Care Medicine|2019Cited by 266
Aztreonam–avibactam versus meropenem for the treatment of serious infections caused by Gram-negative bacteria (REVISIT): a descriptive, multinational, open-label, phase 3, randomised trialYehuda Carmeli, Surbhi Malhotra‐Kumar, José Miguel Cisneros et al.|The Lancet Infectious Diseases|2024Cited by 98